Scarica l'app Stockscreener
2.55
8.05%
0.19
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GDRX Giù?
Forum
Previsione
Goodrx Holdings Inc Borsa (GDRX) Ultime notizie
GoodRx (NASDAQ: GDRX) CAO Thomas Chan reports stock, options and RSUs - Stock Titan
GoodRx offers oral semaglutide starting at $149 per month By Investing.com - Investing.com India
GoodRx expands offerings to now include Ozempic® pill for type 2 diabetes patients - marketscreener.com
GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients - Quantisnow
A new Ozempic pill now starts at $149 a month through GoodRx - Stock Titan
[ARS] GoodRx Holdings, Inc. SEC Filing - Stock Titan
Executive pay, auditor change headline GoodRx (NASDAQ: GDRX) 2026 vote - Stock Titan
What's Going On With GoodRx Stock Thursday? - Sahm
GDRX vs. HQY: Which Stock Is the Better Value Option? - MSN
GoodRx (GDRX) Q2 2024 earnings summary - Quartr
GoodRx won't be participating with TrumpRx: report - MSN
What's going on with GoodRx stock Thursday? - MSN
GoodRx Holdings, Inc. Appoints New Chief Accounting Officer and Files Form 8-K with SEC - Minichart
GoodRx appoints Thomas Chan as chief accounting officer By Investing.com - Investing.com India
GoodRx Names Thomas Chan Chief Accounting Officer - TipRanks
GoodRx appoints Thomas Chan as chief accounting officer - Investing.com
GoodRx names Thomas Chan as Chief Accounting Officer - TradingView
GoodRx (NASDAQ: GDRX) appoints Thomas Chan as new Chief Accounting Officer - Stock Titan
OptimizeRx vs. GoodRx: Which Digital Health Stock is the Better Buy? - The Globe and Mail
GDRX GoodRx Holdings shares climb 4.41 percent after Q4 2025 results despite a minor EPS miss against analyst expectations.Social Trade Signals - Cổng thông tin điện tử tỉnh Tây Ninh
GDRX (GoodRx Holdings Inc.) drops 3.4% today after Q4 2025 EPS narrowly falls short of analyst expectations.Risk Event - Xã Thanh Hà
GoodRx Holdings (GDRX) Sector Leadership | Q4 2025: EPS Misses EstimatesSector Outperform - Cổng thông tin điện tử tỉnh Tây Ninh
Healthcare Technology Stocks Q4 Recap: Benchmarking GoodRx (NASDAQ:GDRX) - Barchart.com
GoodRx Holdings (GDRX) Stock Municipal Bond (Slight Rise) 2026-04-20Crowd Signals - Cổng thông tin điện tử tỉnh Tây Ninh
GoodRx Holdings (GDRX) Stock Trade Ticket (-3.40%) 2026-04-18Stock Community Signals - Cổng thông tin điện tử tỉnh Tây Ninh
GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call - 01net
GoodRx rallies as Wegovy HD rollout targets self-pay market - MSN
GDRX Forecast, Price Target & Analyst Ratings | GOODRX HOLDINGS INC-CLASS A (NASDAQ:GDRX) - ChartMill
GoodRx Rallies As Wegovy HD Rollout Targets Self-Pay Market - Sahm
3 Reasons GDRX is Risky and 1 Stock to Buy Instead - The Globe and Mail
Why GoodRx (GDRX) Stock Is Up Today - Yahoo Finance
[Form 4] GoodRx Holdings, Inc. Insider Trading Activity - Stock Titan
GoodRx (GDRX) director Wendy Lynn Barnes converts RSUs and uses 120,456 shares for taxes - Stock Titan
A higher-dose Wegovy now costs $399 a month through GoodRx - Stock Titan
GoodRx Holdings (GDRX) price target decreased by 38.27% to 2.87 - MSN
Gains Report: What is the next catalyst for GoodRx Holdings IncWeekly Trade Recap & High Accuracy Swing Trade Signals - baoquankhu1.vn
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Nasdaq Moves: How does GoodRx Holdings Inc perform in inflationary periods2026 Recap & Real-Time Volume Spike Alerts - baoquankhu1.vn
GDRX News | GOODRX HOLDINGS INC-CLASS A (NASDAQ:GDRX) - ChartMill
GoodRx brings Lilly's new weight-loss pill to pharmacies nationwide - Stock Titan
1.72%
1.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):